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What Do Patients With Glaucoma See? Visual Symptoms
Reported by Patients With Glaucoma
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Jesse Richman, MD and George L. Spaeth, MD
Abstract: Background: Vision loss from glaucoma has traditionally
been described as loss of “peripheral vision.” In this prospective study,
we aimed to improve our clinical understanding of the visual symptoms
caused by glaucoma by asking patients speciﬁc detailed questions about
how they see. Methods: Patients who were clinically diagnosed with
various types and stages of glaucoma were included. All had
a comprehensive ocular examination, including Octopus visual ﬁeld
testing. Patients were excluded if they had other ocular conditions that
affected their vision, including cornea, lens or retina pathologies.
Patients responded to an oral questionnaire about their visual symptoms.
We investigated the visual symptoms described by patients with
glaucoma and correlated the severity of visual ﬁeld loss with visual
symptoms reported. Results: Ninety-nine patients completed the
questionnaire. Most patients (76%) were diagnosed with primary
open-angle glaucoma. The most common symptoms reported by all
patients, including patients with early or moderate glaucoma, were
needing more light and blurry vision. Patients with a greater amount of
ﬁeld loss (Octopus mean defect .+9.4 dB) were more likely to report
difﬁculty seeing objects to one or both sides, as if looking through dirty
glasses and trouble differentiating boundaries and colors.
Conclusions: Vision loss in patients with glaucoma is not as simple
as the traditional view of loss of peripheral vision. Needing more light
and blurry vision were the most common symptoms reported by patients
with glaucoma.
Key Indexing Terms: Glaucoma; Visual symptoms; Peripheral vision;
Visual ﬁeld; Contrast sensitivity. [Am J Med Sci 2014;348(5):403–409.]
G laucoma is one of the leading causes of blindness world-wide with a prevalence of over 2 million in those aged 40
years and older in the United States.1–3 As the U.S. population
continues to age, the prevalence of glaucoma is projected to
reach 3 million by the year 2020.3
Vision loss due to glaucoma has traditionally been
described as loss of “peripheral vision”; that is, loss of vision
at the outer edges.4–7 Current educational Web sites for the
general public illustrate the loss of vision in glaucoma as
“tunnel vision” or as if one is “looking through a straw”
(Figure 1).8 However, glaucomatous vision loss may involve
not only narrowing of the visual ﬁeld (VF) but also deterio-
ration in the quality of vision.9–13 Several studies have
demonstrated that in addition to VF losses, deterioration of
contrast sensitivity and color discrimination can occur early
in the disease process.10–12 Additionally, patients may report
other visual symptoms due to glaucoma, such as blurriness,
dimness or cloudiness.
Loss of peripheral vision for 1 eye indicates diminished
vision toward the edges of the VF of that eye (Figures 2A and
2B). However, anecdotally, most people with binocular vision
consider their peripheral vision to be sight to the right and left
side of their body (Figure 2C). Patients do not consider nasal
visual loss as “peripheral.” Temporal areas of the VFs are areas
most people consider peripheral vision, yet the temporal areas
of the VF are lost late in the course of glaucoma.14,15 These
linguistic discrepancies further complicate the description of
peripheral visual loss in patients with glaucoma.
The goal of this prospective study was to assess the
visual symptoms described by patients with glaucoma. Cur-
rently, there are no objective methods to assess what patients
experience subjectively. Although quality of life measures
address physical symptoms,16,17 there are no tools to consider
visual symptoms in detail. Our study aimed to improve our
understanding of how glaucoma affects vision from the pa-
tients’ point of view by asking speciﬁc detailed questions about
how they see. A secondary objective of the study was to cor-
relate severity of VF loss with visual symptoms reported.
METHODS
Study Participants
All patients in this study were established patients at the
Glaucoma Service of Wills Eye Hospital. Incoming patients
returning for an ofﬁce visit between July 2011 and December
2011 were screened before their ofﬁce visit to determine their
eligibility for study inclusion. During this time period, all
eligible patients were approached (n 5 102) and 3 patients
refused to participate. Written informed consent was obtained
from all study participants (n5 99). The Research Ethics Board
of Wills Eye Hospital approved this study following the prin-
ciples of the Declaration of Helsinki.
Inclusion criteria required patients to be clinically
diagnosed with glaucoma at a previous visit at least 1 year
before. Patients with primary open-angle glaucoma, normal-
tension glaucoma, pseudoexfoliative glaucoma and pigmentary
glaucoma were included in the study. A diagnosis of glaucoma
was based on characteristic optic nerve damage on slit-lamp
examination (deﬁned as deﬁnite notch in the neuroretinal rim or
absence of neuroretinal rim not due to another known cause)
with corresponding VF defects.18
Patients were excluded if they had other ocular con-
ditions, trauma or surgeries that affected their vision, such as
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cornea, lens or retina pathologies. Patients with previous
glaucoma or cataract surgeries were included. However,
patients who had surgeries within the past year as well as
previous cornea or retina surgeries were excluded. Other
exclusion criteria included patients with extreme refractive
errors such as high myopia (26.0 or higher), high hyperopia
(+6.0 or higher) or astigmatism, acute angle-closure glaucoma,
ocular hypertension, history of stroke, neurologic pathology or
insufﬁcient understanding of English that would prevent the
patient from participating in the study. Cataracts and intraocular
lens opacity were graded based on clinical judgment of nuclear
sclerosis severity. To reduce the effects of cataracts or intraoc-
ular lenses on vision, patients were excluded if they had . +1
nuclear sclerosis, . +1 posterior capsule opaciﬁcation or mul-
tifocal intraocular lenses in either eye.
Questionnaire
A questionnaire was developed based on the most frequent
visual symptoms mentioned by patients in previous studies on
visual disability in glaucoma17,19,20 as well as the clinical experi-
ence of a glaucoma specialist (G.L.S.). An initial version of the
questionnaire was administered to 8 patients (not included in this
study). After interviewer debrieﬁngs, modiﬁcations to question
wording was made for 2 questions to reduce confusion for pa-
tients. The ﬁnal version of the questionnaire consisted of 25 “yes
or no” as well as 3 open-ended questions (Appendix).
A research technician administered the questionnaire
orally to all study participants. A second research technician
administered the same questionnaire for a second time,
a minimum of 15 minutes later, to test for agreement. The
interviewers read the questions out loud as they stand in the
written form of the questionnaire. Patients were asked to report
on the presence of their visual symptoms after correction for
their refractive error and astigmatism. Patients were asked to
use their current spectacles or contact lenses at the time the
questionnaire was given. Trial lenses were available for patients
if they did not have an updated refraction.
Visual Assessment
After the questionnaire was completed, all patients had
a comprehensive ocular examination, including slit-lamp exam-
ination and fundoscopy. VFs were tested monocularly for both
eyes using Octopus 900 Static Perimetry 24-2 SITA standard
(Haag-Streit, Mason, OH). The best-corrected visual acuity
(BCVA) was measured using Snellen’s chart at 20 feet.
FIGURE 1. (A) Patient view with normal vision. (B) Patient view
with glaucoma.8 Loss of vision in glaucoma has been traditionally
described as “tunnel vision” or as if “looking through a straw”
(courtesy: National Eye Institute and National Institutes of Health).
FIGURE 2. (A) Loss of “peripheral vision” can use an eye or
a person as its central reference point. Loss of peripheral vision for
the left eyemeans loss of vision toward the edges of the VF of that
eye. (B) The same is true for the right eye. (C) Loss of peripheral
vision for the person implies loss of sight off to the person’s sides,
either the right and left side (as shown) or above and below. VF,
visual field.
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Statistical Analysis
The study concluded at the end of December 2011, at
which point, 99 patients had been interviewed. All 99 patients
were stratiﬁed by the severity of glaucomatous damage into 1 of
5 categories using the Octopus mean defect (MD) score of their
better eye: 20.7 to +4.4 dB (early glaucoma), +4.5 to +9.4 dB
(moderate glaucoma), +9.5 to +15.3 dB (advanced glaucoma),
+15.4 to +23.1 dB (severe glaucoma) and .23.2 dB (end-stage
glaucoma). This staging system was derived from a panel of
glaucoma specialists who used published literature to convert
the Humphrey’s threshold values to Octopus values.18,21,22 We
looked at differences between age, gender and race between
the 5 MD categories with analysis of variance and Pearson’s
x2 tests. The association between MD category and question-
naire responses was assessed using the Cochran-Armitage
trend test. The Cochran-Armitage trend test assesses for the
presence of an association between a variable with 2 catego-
ries (patient response) and a variable with multiple categories
(MD categories). We used Fisher’s exact test to assess symp-
toms by MD # +9.4 and MD . +9.4 dB. The association
between location of VF defect and visual symptoms reported
was also determined using Fisher’s exact test. Data was
analyzed using SAS Analytics Pro statistics software, version
9.2 (SAS Institute, Inc, Cary, NC).
We transcribed the responses from the open-ended
questions looking for any descriptor of visual symptoms.
Words such as blurry, blurred and blurriness were all consid-
ered to be derived from 1 descriptor, blur. When descriptors
such as foggy, blurry and hazy were used, they were considered
different descriptors. The frequency of descriptors was tallied.
The location of all VF defects was documented by better
eye and worse eye. In addition, we compared the agreement of
laterality of ﬁeld loss and the laterality of symptoms reported.
When the person reported difﬁculty seeing to the left with
corresponding left-sided ﬁeld loss, the person was listed as
“ﬁeld and symptoms” agree. When the person reported difﬁ-
culty seeing to the left and the VF loss was right sided, the
person was listed as “ﬁeld and symptoms” disagree and vice
versa. If the person did not report difﬁculty seeing to one or
both sides and did not have lateral ﬁeld defects, then the person
was listed as “ﬁeld and symptoms” agree.
RESULTS
A summary of patient characteristics is displayed in
Table 1. The average number of years diagnosed with glaucoma
was 8.4 years. For each MD group, the average number of years
diagnosed with glaucoma was 7.7 years for early, 7.6 years for
moderate, 8.9 years for advanced, 8.5 years for severe and 17.2
years for end stage. There were no age or gender differences
between the 5 MD groups, but race signiﬁcantly varied
(Table 2). Most patients (75%) had a BCVA of 20/20 in their
better eye, and 91% of patients had a BCVA of 20/30 or better.
When considering all patients, 92% reported at least 1
visual symptom after correction for their refractive error and
astigmatism. Table 3 displays the most common symptoms
reported by all patients. For patients with early or moderate
glaucoma without cataract (n 5 33), the most common symp-
toms reported were needing more light (58%), blurry vision
(52%) and seeing glare (52%).
For the 8 patients (8%) who did not report any visual
symptoms, the average MD of the better eye was 4.5 dB (range,
0.9–7.9 dB). From the VFs of the better eye, 4 patients had mild
generalized ﬁeld depression, 3 had an arcuate scotoma and 1
had a paracentral scotoma. All patients had early or moderate
glaucoma by MD category and a BCVA #20/40.
Patients were asked the open-ended question: “How is
your vision different?” from either 5 or 15 years ago. The most
common response was “blurriness” (15%). Although we
received similar comments from other patients, 1 patient ex-
pressed, “The world seems more blurry. It’s just not real clear.
Things used to be crisper”. Another patient described, “It’s like
looking underwater.” Other common responses to describe the
change in vision were “fuzzy” (6%), “less clear” (6%), “harder
TABLE 1. Characteristics of 99 questionnaire respondents
Characteristic
No. of
participants
Age Mean (SD) 5 70 (13.5) 99
Gender Female 54
Male 45
Race White 66
African American 29
Other 4
MD category Early (MD, 20.7 to +4.4 dB) 47
Moderate (MD, +4.5 to +9.4 dB) 26
Advanced (MD, +9.5 to +15.3 dB) 14
Severe (MD, +15.4 to +23.1 dB) 7
End stage (MD, .23.2 dB) 5
Type of
glaucoma
Primary open-angle glaucoma 75
Chronic angle-closure glaucoma 14
Pseudoexfoliative glaucoma 6
Pigmentary glaucoma 4
Lens status No nuclear sclerosis or other
apparent lens change
46
Trace nuclear sclerosis 13
+1 Nuclear sclerosis 33
+1 Posterior capsular opacity 7
MD, mean defect.
TABLE 2. Age, gender and race by MD category
MD category
PEarly Moderate Advanced Severe End stage
Age 67 (SD: 13) 76 (SD: 13) 68 (SD: 10) 78 (SD: 14) 81 (SD: 13) 0.13
Gender (female:male) 23:24 15:11 8:6 4:3 4:1 0.21
Race (white:other) 37:10 14:12 9:5 6:1 1:4 0.02a
a P , 0.05.
MD, mean defect.
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to read” (5%), “hazy” (4%) and “cloudy” (2%). No patient
complained of “tunnel vision” or loss of side vision. No patient
provided novel information from the open-ended questions that
were not addressed in the questionnaire.
Patients in a higher MD category were more likely to
report 6 visual symptoms, shown in Table 4. Compared with
patients with early or moderate glaucoma, those with ﬁeld loss
worse than MD of +9.4 dB were signiﬁcantly more likely to
report these 6 symptoms (P # 0.05).
Of the 198 eyes in the study, 196 were diagnosed with
glaucoma. Two participants had unilateral glaucoma. Of the
196 eyes, there was agreement between laterality of ﬁeld loss
and laterality of symptoms 68% of the time, and no agreement
20% of the time. For 24 eyes (12%), it was not possible to
determine whether there was agreement between laterality of
ﬁeld loss and laterality of symptoms reported.
Table 5 provides a detailed account of the location of VF
defects by better eye and worse eye. There was no signiﬁcant
association between location of VF and symptoms reported for
the 3 most common symptoms (P 5 0.89).
Patients were administered the same questionnaire twice,
a minimum of 15 minutes apart. The average percent agreement
was 0.89 (range, 0.73–1) between the 2 responses, and the
average Kappa for agreement was 0.60.
DISCUSSION
The purpose of this study was to determine how
glaucoma affects vision from patients’ point of view. We
administered a questionnaire to patients with glaucoma to deter-
mine visual symptoms reported, and we correlated the severity
of VF loss with symptoms reported.
In contrast to the traditional view of glaucoma,4–7 loss of
peripheral vision was not the most common symptom reported.
Needing more light and blurry vision were the most common
symptoms reported, and these symptoms were not associated
with any speciﬁc area of VF defect. These symptoms may be
more consistent with loss of contrast sensitivity than ﬁeld loss.
Decreased contrast sensitivity is an established ﬁnding in pa-
tients with glaucoma, which may be contributing to reduced
image quality.11,23–25 The pathological thinning of the nerve
ﬁber layer that occurs in glaucoma may explain why blurry
vision was one of the most commonly reported symptoms.26,27
Other symptoms reported by more than 25% of patients
in our study included seeing glare, letters appearing faded when
reading, seeing too much light or seeing as if looking through
dirty glasses. These reported symptoms suggest that decreased
image quality, not simply VF loss or “tunnel vision,” plays an
important role in glaucoma. No patient in this study reported
“tunnel vision.” Crabb et al28 also found that “tunnel vision”
does not accurately describe what patients with glaucoma per-
ceive. They asked patients with primary open-angle glaucoma
to select 1 image of 6 choices that most closely represented their
perception of their VF loss, and the most frequently selected
images were blurred patches and missing patches. No patient in
their study selected the image with a distinct black tunnel or
black patches.28
Along with a decrease in the quality of vision, our study
found that the fourth, sixth and ninth most common complaints
were related to difﬁculties seeing to 1 or both sides. There was
an agreement between laterality of ﬁeld loss and laterality of
symptoms reported approximately 65% of the time, suggesting
that ﬁeld loss plays a role in difﬁculty seeing to the sides.
However, most patients in our study did not have a constricted
VF. There was no agreement between laterality of ﬁeld loss and
laterality of symptoms in 20% of eyes, suggesting that it may
not be simply the VF accounting for symptoms reported.
Deterioration of image quality or reduced contrast sensitivity
TABLE 3. Most common visual symptoms reported by
all patients
Symptom % Reported
Needing more light 57
Blurry vision 55
Seeing glare 46
Difﬁculty seeing objects off to both sides 36
Letters appearing faded when reading 30
Difﬁculty seeing objects off to left side 27
Seeing too much light 26
Area(s) darker or missing 26
Seeing as if looking through dirty glasses 25
Difﬁculty seeing objects off to right side 24
Seeing as if looking through clouds 23
TABLE 4. Association between MD category and visual symptoms reporteda
Symptom Patient response
MD category (n)
PEarly Moderate Advanced Severe End stage
Difﬁculty seeing objects to both sides Yes 12 8 7 5 4 ,0.001
No 35 18 7 2 1
Difﬁculty seeing objects to left side Yes 7 8 3 4 5 ,0.001
No 40 18 11 3 0
Difﬁculty seeing objects to right side Yes 4 7 6 3 4 ,0.001
No 43 19 8 4 1
Trouble differentiating colors Yes 5 4 3 2 4 0.001
No 42 22 11 5 1
Trouble differentiating boundaries Yes 5 2 2 2 3 0.01
No 42 24 12 5 2
As if looking through dirty glasses Yes 8 5 7 2 3 0.01
No 39 21 7 5 2
a Only symptoms with a statistically signiﬁcant association (P , 0.05) are shown.
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at the “periphery” may also play a role in difﬁculty seeing to 1
or both sides, as shown in Figure 3. This is supported by Tochel
et al29 who reported that patients with glaucoma have abnor-
mally high-contrast thresholds (ie, low-contrast sensitivity)
without correlation to ﬁeld loss. It was not possible to determine
agreement between laterality of ﬁeld loss and laterality of symp-
toms reported for 24 eyes in our study. These patients had
a nonspeciﬁc pattern of ﬁeld loss or paracentral scotoma that
was neither predominately right sided or left sided.
With increasing amounts of ﬁeld loss, the likelihood of
having visual symptoms increased, as would be expected. For
each of the 6 symptoms that showed an association with higher
MD score, patients with ﬁeld loss worse than MD +9.4 dB were
more likely to report symptoms. This suggests that patients can
have signiﬁcant ﬁeld loss before reporting visual symptoms.
A previous study speculated that patients with glaucomatous
ﬁeld defects may experience cortical reorganization or a ﬁlling
in phenomenon.30 The defect may be concealed by the colors and
patterns of the surroundings such that the brain composes a plau-
sible image.30 In the study by Crabb et al28, 16% of patients
selected the image with missing patches in their vision, which
was designed to illustrate the ﬁlling in phenomenon. Similarly,
our study found that 26% of patients reported areas darker or
missing in their vision. These ﬁndings suggest that what patients
actually see is more complex than VF alone, and that patients
with glaucoma do not simply develop “tunnel vision.”
Most patients in our study had good visual acuity, but
92% of patients reported at least 1 visual symptom. Patients may
have poor image quality even in those with good visual acuity.11
All patients who did not report any visual symptoms had VF
defects in their better eye, indicating the asymptomatic nature
of early disease even in the presence of objective VF defects.
Teaching people that glaucoma causes loss of peripheral
vision may teach them to ignore the early signs of glaucoma. We
found that the most common symptoms reported by patients with
early or moderate glaucoma were needing more light, blurry vision
and seeing glare. Even mild or moderate glaucomatous vision loss
is associated with signiﬁcant visual disability and reduced ability to
perform visually related tasks, such as reading or driving.17,31,32
Furthermore, there is reduced quality of life and increased depres-
sion rates among patients with increasingly severe glaucoma.33,34
Earlier detection of disease and implementation of treatment may
help preserve visual function and improve quality of life. Providing
insight about visual symptoms due to glaucoma may be helpful for
clinicians, patients and researchers. We therefore recommend that
these symptoms be emphasized to patients at risk for glaucoma in
public awareness campaigns and in educational materials.
An important limitation of this study was the inability to
determine the actual cause for the visual symptoms described.
Since other known causes for decreased vision were excluded,
most had excellent visual acuity, and none had a visually
symptomatic cataract, the presumption is that the cause for the
symptoms was glaucoma.
TABLE 5. Areas of VF defects by better eye and worse eye
Areas of VF defect
Better eye
(n)
Worse eye
(n)
Normal 18 3
Nonspeciﬁc pattern of depressed
points
17 13
Mild generalized ﬁeld depression 12 9
Nasal step 11 10
Paracentral scotoma 4 7
Superior arcuate defect 18 11
Inferior arcuate defect 2 5
Both arcuate defect and nasal step 6 7
Both superior and inferior arcuate
defect
2 11
Constricted VF 5 17
Severe generalized ﬁeld depression 2 6
Total 97 99
FIGURE 3. A graphic illustration
of a possible progression of visual
loss in a patient with glaucoma.
(A) Normal vision, early glau-
coma. (B) Early loss of contrast
sensitivity. (C) Severe loss of
contrast sensitivity. (D) Light
paracentral and arcuate scoto-
mas. (E) Dense scotomas. (F)
Advanced bilateral disease. (G)
Very advanced bilateral disease.
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There are several other limitations. The nature of symp-
toms reported suggests that loss of contrast sensitivity plays role
in glaucoma, but we cannot directly verify loss of contrast
sensitivity in our patients because it was not measured. Symptoms
reported may have been due to loss of contrast sensitivity, acuity
or ﬁeld, and their relative impacts are not clear. We did not test
for near visual acuity, which may also have contributed to some
of the symptoms reported, such as blurry vision.
Although we assessed visual symptoms by asking how
patients see, we did not determine which eye was responsible for
the symptoms reported. It has been shown that functional ability
and quality of life is closely related to vision status in the better
eye,35–37 so we analyzed patient responses using the better eye
MD. Previous studies have found that monocular VFs overesti-
mate vision loss compared with binocular integrated VFs.38,39 This
is a limitation of our study, and our future studies will consider
including both monocular and integrated VF assessments. Also,
after stratiﬁcation of our patients by MD category, race differed
between the 5 groups, which may have confounded our results.
Despite these limitations, this is a novel study investi-
gating visual symptoms reported by patients with glaucoma.
We asked patients speciﬁc detailed questions about how they
see to gain a better understanding of vision loss caused by
glaucoma. Our study found that the most common symptoms
reported by all patients, including those with early or moderate
glaucoma, were needing more light and blurry vision. Vision
loss in patients with glaucoma is not as simple as the traditional
view of loss of peripheral vision or “tunnel vision.”
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“What do patients with glaucoma see?” study questionnaire
1) Do you wear glasses? YES NO
2) Is your vision normal? YES NO
3) (If you wear glasses, then with them) do you see as well as you did 5 years ago? YES NO
If “NO,” go to question 4
If “YES,” go to question 5
4) How is your vision different?
5) (If you wear glasses, then with them) do you see as well as you did 15 years ago? YES NO
If “NO,” go to question 6
If “YES,” go to question 7
6) How is your vision different?
7) (If you wear glasses and you feel your vision is worse now versus 5/15 years ago), Is your
vision worse because you need your glasses more?
YES NO
8) When you wear your glasses, do you see as well as you did 15 years ago? YES NO
9) Is your vision “blurred”? YES NO
10) Is your vision “grainy”? YES NO
11) When light shines directly on your eyes, do you see a glare? YES NO
12) When you look at a picture, do you have trouble differentiating the boundaries? YES NO
13) Does it seem as if the world is darker? YES NO
14) Do you have difﬁculty seeing objects off to both sides? YES NO
15) Does it seem as if you are looking through a veil? YES NO
16) Do you need more light? YES NO
17) Do you have difﬁculty seeing objects off to the left side? YES NO
18) Does it seem as if you are looking through clouds? YES NO
19) Is there too much light? YES NO
20) Are there areas you do not see? YES NO
21) Does it seem as if you are looking through dirty glasses? YES NO
22) Do you have problems with colors? YES NO
23) Do you have difﬁculty seeing objects off to the right side? YES NO
24) When you are reading, do the letters seem faded? YES NO
25) (If participant has mentioned a difference in the right vs. left eye) Have you tried
seeing with only 1 eye at a time by covering 1 eye and looking with the other?
YES NO
If “YES,” go to question 26
If “NO,” go to question 27
26) What do you see when you do that?
27) Is there an area or are there areas which seems darker or even missing? YES NO
If “YES,” where are the missing areas? (check all that apply)
Off to the left side
Off to the right side
Off to both sides
Straight ahead
Up above
Down below
Somewhere else
APPENDIX
What Do Patients With Glaucoma See?
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